Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A new topical preparation for the treatment of head lice has been approved by the FDA. Ivermectin is a macrocyclic lactone antibiotic that has been used orally both on and off label for head lice since 2001. This new formulation is a topical lotion (oral invermectin is not approved in the United States). It is manufactured by DPT Laboratories and is distributed by Sanofi Pasteur, Inc., as Sklice.

Ivermectin Lotion 0.5% (Sklice™)